Business Description
Zylox-Tonbridge Medical Technology Co Ltd
ISIN : CNE100004JD2
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.04 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.73 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.2 | |||||
Beneish M-Score | -2.07 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 159.1 | |||||
3-Year EBITDA Growth Rate | 25.2 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | 13 | |||||
3-Year Book Growth Rate | 75.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.79 | |||||
9-Day RSI | 51.73 | |||||
14-Day RSI | 52.09 | |||||
6-1 Month Momentum % | -9.23 | |||||
12-1 Month Momentum % | -13.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.4 | |||||
Quick Ratio | 4.88 | |||||
Cash Ratio | 4.75 | |||||
Days Inventory | 378.06 | |||||
Days Sales Outstanding | 0.73 | |||||
Days Payable | 69.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | 0.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.95 | |||||
Operating Margin % | -27.37 | |||||
Net Margin % | -14.92 | |||||
FCF Margin % | -17.59 | |||||
ROE % | -2.54 | |||||
ROA % | -2.36 | |||||
ROIC % | -9.62 | |||||
ROC (Joel Greenblatt) % | -16.67 | |||||
ROCE % | -2.49 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.06 | |||||
PB Ratio | 1.03 | |||||
Price-to-Tangible-Book | 1.03 | |||||
Price-to-Operating-Cash-Flow | 32.34 | |||||
EV-to-EBIT | -23.05 | |||||
EV-to-EBITDA | -23.26 | |||||
EV-to-Revenue | 3.38 | |||||
EV-to-FCF | -18.4 | |||||
Price-to-Net-Current-Asset-Value | 2.25 | |||||
Price-to-Net-Cash | 2.64 | |||||
Earnings Yield (Greenblatt) % | -4.33 | |||||
FCF Yield % | -2.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zylox-Tonbridge Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 67.884 | ||
EPS (TTM) (€) | -0.031 | ||
Beta | 0 | ||
Volatility % | 55.43 | ||
14-Day RSI | 52.09 | ||
14-Day ATR (€) | 0.032192 | ||
20-Day SMA (€) | 1.188 | ||
12-1 Month Momentum % | -13.87 | ||
52-Week Range (€) | 0.905 - 1.46 | ||
Shares Outstanding (Mil) | 327.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zylox-Tonbridge Medical Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zylox-Tonbridge Medical Technology Co Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Zylox-Tonbridge Medical Technology Co Ltd Frequently Asked Questions
What is Zylox-Tonbridge Medical Technology Co Ltd(FRA:818)'s stock price today?
When is next earnings date of Zylox-Tonbridge Medical Technology Co Ltd(FRA:818)?
Does Zylox-Tonbridge Medical Technology Co Ltd(FRA:818) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |